Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ingevity (NGVT) Equity Average (2016 - 2025)

Historic Equity Average for Ingevity (NGVT) over the last 10 years, with Q3 2025 value amounting to $129.4 million.

  • Ingevity's Equity Average fell 4816.74% to $129.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.4 million, marking a year-over-year decrease of 4816.74%. This contributed to the annual value of $413.3 million for FY2024, which is 3783.56% down from last year.
  • Ingevity's Equity Average amounted to $129.4 million in Q3 2025, which was down 4816.74% from $177.6 million recorded in Q2 2025.
  • Ingevity's Equity Average's 5-year high stood at $719.9 million during Q2 2023, with a 5-year trough of $129.4 million in Q3 2025.
  • Over the past 5 years, Ingevity's median Equity Average value was $659.2 million (recorded in 2021), while the average stood at $533.6 million.
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 3166.83% in 2021, then crashed by 6965.41% in 2024.
  • Ingevity's Equity Average (Quarter) stood at $659.2 million in 2021, then increased by 1.05% to $666.1 million in 2022, then increased by 1.34% to $675.0 million in 2023, then plummeted by 69.65% to $204.8 million in 2024, then plummeted by 36.83% to $129.4 million in 2025.
  • Its Equity Average stands at $129.4 million for Q3 2025, versus $177.6 million for Q2 2025 and $214.9 million for Q1 2025.